As increased NADPH oxidase-driven ROS generation can lead to the generation of a malignant phenotype in PCa by modulating various signaling cascades [105], this emerging candidate may prove to be an effective target for therapeutic intervention. This evidence concerns the gene FMO5 and posterior cortical atrophy.